SCHEMBL4511150

SCHEMBL4511150

CC(=O)c1cc2c(/C(C)=C/C(=O)N3CCOCC3)ccc(OC(c3ccccc3)c3ccccc3)c2o1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 5/20 0.39
PDE4B Q07343 5/20 0.39
PDE4C Q08493 5/20 0.39
PDE4D Q08499 5/20 0.39
SMN1; SMN2 Q16637 3/20 0.37
HPGD P15428 3/20 0.37
KDM4E B2RXH2 3/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
APP P05067 1/20 0.37
LTB4R Q15722 1/20 0.37
LTB4R2 Q9NPC1 1/20 0.37
PTGS2 P35354 1/20 0.36
ALDH1A1 P00352 4/20 0.36
GAA P10253 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4511155 1.00 PDE4A (0.39) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL4511156 1.00 PDE4A (0.39) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL4510379 0.92 LTB4R (0.45) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL4510372 0.92 LTB4R (0.45) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL4510375 0.92 LTB4R (0.45) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL4500639 0.91 RXFP1 (0.39) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL4500636 0.91 RXFP1 (0.39) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL4500642 0.91 RXFP1 (0.39) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL4518249 0.88 ALDH1A1 (0.41) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL4518260 0.88 ALDH1A1 (0.41) PDE4APDE4BPDE4CPDE4DSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7638540-B2 Benzofuran compound and medicinal composition containing the same THE NEW INDUSTRY RESEARCH ORGANIZATION (JP) 2009-12-29 US disclosed
US-7638540-B2 Benzofuran compound and medicinal composition containing the same THE NEW INDUSTRY RESEARCH ORGANIZATION (JP) 2009-12-29 US disclosed
US-7638540-B2 Benzofuran compound and medicinal composition containing the same THE NEW INDUSTRY RESEARCH ORGANIZATION (JP) 2009-12-29 US disclosed
US-20060194851-A1 Benzofuran compound and medicinal composition containing the same NEW INDUSTRY RESEARCH ORGANIZATION, THE (JP) 2006-08-31 US disclosed
EP-1627873-A1 BENZOFURAN COMPOUND AND MEDICINAL COMPOSITION CONTAINING THE SAME The New Industry Research Organization (JP) 2006-02-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194851-A1 Benzofuran compound and medicinal composition containing the same LTB4R2, LTC4S, LTB4R PDE4A 2659/4885PDE4B 2775/4885PDE4C 3532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.